Keck School of Medicine of USC and Hamamatsu Photonics launch digital pathology collaboration focused on real-world workflow improvement

2026/05/29
  • Hamamatsu Corporation

New collaboration brings together USC pathology clinical excellence and Hamamatsu imaging expertise to explore innovative approaches to pathology workflows, advancing systems and data integration while helping define the future of connected pathology.

Hamamatsu Corporation announced a new collaboration with the Keck School of Medicine of USC focused on real-world digital pathology workflow improvement. As part of the project, multiple Hamamatsu NanoZoomer slide scanning systems will be installed to support practice-based pathology workflow research led by W. Dean Wallace, MD, Professor of Pathology and Laboratory Medicine at the Keck School of Medicine of USC.

 

This collaboration is intended to address three important questions around the adoption and implementation of digital pathology: What efficiencies can be achieved when a digital pathology workflow is designed in a high-functioning real-world laboratory environment? How can those efficiencies translate into operational improvements that matter both within the laboratory and at the patient level? And how can that knowledge be shared so other facilities can benefit from those insights?

 

“For 70 years, Hamamatsu has applied photonics to real-world challenges in pursuit of its mission to improve life through photonics technologies,” said Earl Hergert, President, Hamamatsu Corporation. “Hamamatsu’s experience and hardware are embedded in many instruments across many fields, especially medicine. Through this collaboration, we are bringing that dedication to innovation directly into the laboratory. We are proud to work with Dr. Wallace and the entire USC pathology team to help advance digital pathology in a way that is grounded in real-world experience and focused on improvements that matter both within the laboratory and at the patient level. This collaboration reflects the evolution of our role in medical research, and we are delighted to do this with such a strong collaborator as USC.”